A Pharmacokinetics Study of Intravenous Ascorbic Acid

Completed · Phase 1

Conditions studied: Pharmacokinetics

In brief

This is a Phase 1, single-dose study to evaluate the pharmacokinetics of intravenous Ascorbic Acid.

Key facts

Study ID

NCT02534753

Run by

McGuff Pharmaceuticals, Inc.

People needed

8

Starts

2015-09-01

Expected to finish

2016-01-01

Last updated by the study team

2016-03-23

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Is between the ages of 18 and 45 years, inclusive.
• Has a body mass index (BMI) between 18 and 32 kg/m2.
• Of sound health and has the ability to understand the requirements of the study and is willing to comply with all study requirements and procedures.

You may not qualify if…

• Participates in activities that would not allow accurate evaluation of the pharmacokinetics of Ascorbic Acid
• Medical or physical conditions that would not allow safe participation and/or accurate evaluation of the pharmacokinetics of Ascorbic Acid
• Has participated in an investigational drug study within the 30 days prior to CRU admission.

Where it is running

• Virginia Commonwealth University — Richmond, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.